vs
CLEANSPARK, INC.（CLSK）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是CLEANSPARK, INC.的1.1倍（$197.9M vs $181.2M），REPLIGEN CORP净利率更高（6.7% vs -209.0%，领先215.7%），REPLIGEN CORP同比增速更快（13.6% vs 11.6%），REPLIGEN CORP自由现金流更多（$17.6M vs $-198.1M），过去两年CLEANSPARK, INC.的营收复合增速更高（106.4% vs 14.4%）
CleanSpark Inc.是一家总部位于美国的可持续技术企业，核心业务包含两大板块：一是依托可再生能源与闲置能源开展低碳比特币挖矿业务，二是为北美地区的工商业及公共部门客户提供微电网设计、部署与运营服务。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
CLSK vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.1倍
$181.2M
营收增速更快
RGEN
高出2.0%
11.6%
净利率更高
RGEN
高出215.7%
-209.0%
自由现金流更多
RGEN
多$215.6M
$-198.1M
两年增速更快
CLSK
近两年复合增速
14.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $181.2M | $197.9M |
| 净利润 | $-378.7M | $13.3M |
| 毛利率 | 47.2% | 52.5% |
| 营业利润率 | -174.7% | 9.0% |
| 净利率 | -209.0% | 6.7% |
| 营收同比 | 11.6% | 13.6% |
| 净利润同比 | -253.5% | 143.9% |
| 每股收益（稀释后） | — | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLSKRGEN
| Q4 25 | $181.2M | $197.9M | ||
| Q3 25 | — | $188.8M | ||
| Q2 25 | — | $182.4M | ||
| Q1 25 | — | $169.2M | ||
| Q4 24 | — | $174.1M | ||
| Q3 24 | $89.3M | $154.9M | ||
| Q2 24 | $104.1M | $154.1M | ||
| Q1 24 | $111.8M | $151.3M |
净利润CLSKRGEN
| Q4 25 | $-378.7M | $13.3M | ||
| Q3 25 | — | $14.9M | ||
| Q2 25 | — | $14.9M | ||
| Q1 25 | — | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $-62.2M | $-654.0K | ||
| Q2 24 | $-236.2M | $3.3M | ||
| Q1 24 | $126.7M | $2.1M |
毛利率CLSKRGEN
| Q4 25 | 47.2% | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | 36.0% | 50.0% | ||
| Q2 24 | 56.6% | 49.8% | ||
| Q1 24 | 69.3% | 49.5% |
营业利润率CLSKRGEN
| Q4 25 | -174.7% | 9.0% | ||
| Q3 25 | — | 8.9% | ||
| Q2 25 | — | 7.6% | ||
| Q1 25 | — | 3.9% | ||
| Q4 24 | — | -17.7% | ||
| Q3 24 | -73.5% | -5.1% | ||
| Q2 24 | -239.2% | 1.0% | ||
| Q1 24 | — | 1.3% |
净利率CLSKRGEN
| Q4 25 | -209.0% | 6.7% | ||
| Q3 25 | — | 7.9% | ||
| Q2 25 | — | 8.2% | ||
| Q1 25 | — | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | -69.6% | -0.4% | ||
| Q2 24 | -226.9% | 2.2% | ||
| Q1 24 | 113.4% | 1.4% |
每股收益（稀释后）CLSKRGEN
| Q4 25 | — | $0.24 | ||
| Q3 25 | — | $0.26 | ||
| Q2 25 | — | $0.26 | ||
| Q1 25 | — | $0.10 | ||
| Q4 24 | — | $-0.55 | ||
| Q3 24 | — | $-0.01 | ||
| Q2 24 | — | $0.06 | ||
| Q1 24 | — | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $458.1M | $767.6M |
| 总债务越低越好 | $1.8B | $542.2M |
| 股东权益账面价值 | $1.4B | $2.1B |
| 总资产 | $3.3B | $2.9B |
| 负债/权益比越低杠杆越低 | 1.29× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资CLSKRGEN
| Q4 25 | $458.1M | $767.6M | ||
| Q3 25 | — | $748.7M | ||
| Q2 25 | — | $708.9M | ||
| Q1 25 | — | $697.2M | ||
| Q4 24 | — | $757.4M | ||
| Q3 24 | $121.2M | $784.0M | ||
| Q2 24 | $126.1M | $809.1M | ||
| Q1 24 | — | $780.6M |
总债务CLSKRGEN
| Q4 25 | $1.8B | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | $7.2M | — | ||
| Q2 24 | $1.3M | — | ||
| Q1 24 | $5.1M | — |
股东权益CLSKRGEN
| Q4 25 | $1.4B | $2.1B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | — | $2.1B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | $1.8B | $2.0B | ||
| Q2 24 | $1.4B | $2.0B | ||
| Q1 24 | $1.5B | $2.0B |
总资产CLSKRGEN
| Q4 25 | $3.3B | $2.9B | ||
| Q3 25 | — | $2.9B | ||
| Q2 25 | — | $2.9B | ||
| Q1 25 | — | $2.9B | ||
| Q4 24 | — | $2.8B | ||
| Q3 24 | $2.0B | $2.8B | ||
| Q2 24 | $1.5B | $2.9B | ||
| Q1 24 | $1.5B | $2.8B |
负债/权益比CLSKRGEN
| Q4 25 | 1.29× | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-161.1M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-198.1M | $17.6M |
| 自由现金流率自由现金流/营收 | -109.3% | 8.9% |
| 资本支出强度资本支出/营收 | 20.4% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $-626.9M | $93.9M |
8季度趋势，按日历期对齐
经营现金流CLSKRGEN
| Q4 25 | $-161.1M | $25.7M | ||
| Q3 25 | — | $48.1M | ||
| Q2 25 | — | $28.6M | ||
| Q1 25 | — | $15.0M | ||
| Q4 24 | — | $39.2M | ||
| Q3 24 | $-233.7M | $49.3M | ||
| Q2 24 | $-58.4M | $42.2M | ||
| Q1 24 | $-44.8M | $44.7M |
自由现金流CLSKRGEN
| Q4 25 | $-198.1M | $17.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | — | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | $-299.8M | $42.3M | ||
| Q2 24 | $-68.7M | $37.4M | ||
| Q1 24 | $-60.3M | $36.4M |
自由现金流率CLSKRGEN
| Q4 25 | -109.3% | 8.9% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | -335.8% | 27.3% | ||
| Q2 24 | -66.0% | 24.3% | ||
| Q1 24 | -54.0% | 24.0% |
资本支出强度CLSKRGEN
| Q4 25 | 20.4% | 4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | 74.0% | 4.5% | ||
| Q2 24 | 9.9% | 3.1% | ||
| Q1 24 | 13.8% | 5.5% |
现金转化率CLSKRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | -0.35× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
